Compare RRX & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RRX | BIO |
|---|---|---|
| Founded | 1955 | 1952 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Laboratory Analytical Instruments |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.0B | 7.2B |
| IPO Year | 1994 | N/A |
| Metric | RRX | BIO |
|---|---|---|
| Price | $202.54 | $270.40 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 4 |
| Target Price | $208.90 | ★ $358.50 |
| AVG Volume (30 Days) | ★ 971.7K | 296.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 0.70% | N/A |
| EPS Growth | ★ 42.86 | N/A |
| EPS | ★ 4.20 | N/A |
| Revenue | ★ $3,257,100,000.00 | N/A |
| Revenue This Year | $4.17 | $2.51 |
| Revenue Next Year | $10.74 | $3.17 |
| P/E Ratio | $47.89 | ★ $9.72 |
| Revenue Growth | ★ 5.21 | N/A |
| 52 Week Low | $90.56 | $211.43 |
| 52 Week High | $229.30 | $343.12 |
| Indicator | RRX | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 51.08 | 39.98 |
| Support Level | $136.02 | $266.71 |
| Resistance Level | $227.65 | $290.01 |
| Average True Range (ATR) | 8.92 | 7.01 |
| MACD | -4.46 | 0.54 |
| Stochastic Oscillator | 46.83 | 20.91 |
Regal Rexnord Corp is in the engineering and manufacturing of industrial powertrain solutions, power transmission components, electric motors, electronic controls, air-moving products, and specialty electrical components and systems, serving customers around the world. The four operating segments include Commercial Systems, Industrial Systems, Climate Solutions, and Motion Control Solutions.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.